Ignite Creation Date:
2024-05-06 @ 7:48 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06146413
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-11-29
First Post:
2023-11-19
Brief Title:
Triggering Oocyte Maturation in Normoresponders Using Double Trigger or HCG Trigger
Sponsor:
Bedaya Hospital
Organization:
Bedaya Hospital
Study Overview
Official Title:
Triggering Oocyte Maturation in Normoresponders Using Double Trigger or HCG Trigger A Randomized Controlled Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Doubtrig
Brief Summary:
The aim of this study is to compare the efficacy double trigger co-administration of GnRH agonist with HCG 40 and 34 h prior to ovum pick-up respectively with HCG trigger in inducing oocyte maturation
Detailed Description:
Several studies revealed that the double trigger regimen was effective in the treatment of patients with a history of immature oocytes retrieved or with suboptimal oocytes yield
The investigators designed this randomized controlled trial to compare the efficacy double trigger with HCG trigger in inducing oocyte maturationin normoreponders undergoing IVF-ET
The investigators designed this randomized controlled trial to compare the efficacy double trigger with HCG trigger in inducing oocyte maturationin normoreponders undergoing IVF-ET
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None